Loading company…
Navi Seed develops robotic systems for minimally invasive tumor surgery.
Navi Seed's radioactive particle implantation robot supports percutaneous puncture positioning and path management. It is intended for treating solid tumors in areas including the head, neck, chest, abdomen and pelvis. Founded in 2021, the company is based in Suzhou, China.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in